These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 21275762)

  • 1. Survey of radioiodine therapy safety practices highlights the need for user-friendly recommendations.
    Kloos RT
    Thyroid; 2011 Feb; 21(2):97-9. PubMed ID: 21275762
    [No Abstract]   [Full Text] [Related]  

  • 2. Current safety practices relating to I-131 administration for diseases of the thyroid: a survey of physicians and allied practitioners.
    Greenlee C; Burmeister LA; Butler RS; Edinboro CH; Morrison SM; Milas M;
    Thyroid; 2011 Feb; 21(2):151-60. PubMed ID: 21275765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The SNMMI practice guideline for therapy of thyroid disease with 131I 3.0.
    Silberstein EB; Alavi A; Balon HR; Clarke SE; Divgi C; Gelfand MJ; Goldsmith SJ; Jadvar H; Marcus CS; Martin WH; Parker JA; Royal HD; Sarkar SD; Stabin M; Waxman AD
    J Nucl Med; 2012 Oct; 53(10):1633-51. PubMed ID: 22787108
    [No Abstract]   [Full Text] [Related]  

  • 4. Radiation safety in the treatment of patients with thyroid diseases by radioiodine 131I : practice recommendations of the American Thyroid Association.
    ; Sisson JC; Freitas J; McDougall IR; Dauer LT; Hurley JR; Brierley JD; Edinboro CH; Rosenthal D; Thomas MJ; Wexler JA; Asamoah E; Avram AM; Milas M; Greenlee C
    Thyroid; 2011 Apr; 21(4):335-46. PubMed ID: 21417738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of toxicological hazards from medical radioiodine administration.
    Van Dyke M; Punja M; Hall MJ; Kazzi Z
    J Med Toxicol; 2015 Mar; 11(1):96-101. PubMed ID: 25008160
    [No Abstract]   [Full Text] [Related]  

  • 6. Administering radioiodine treatment; alternatives to nuclear medicine prescribing.
    Singh R; Aitken M
    Eur J Nucl Med Mol Imaging; 2007 Mar; 34(3):426. PubMed ID: 17109168
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hypothyroidism after the elimination of the thyroid gland with radioiodine I131].
    Vána S; Nĕmec J; Reisenauer R
    Vnitr Lek; 1979 Aug; 25(8):768-75. PubMed ID: 506080
    [No Abstract]   [Full Text] [Related]  

  • 8. [Procedures for the radioiodine test].
    Dietlein M; Dressler J; Eschner W; Leisner B; Reiners C; Schicha H
    Nuklearmedizin; 1999; 38(6A):211-2. PubMed ID: 10510808
    [No Abstract]   [Full Text] [Related]  

  • 9. Radioiodine for the treatment of thyroid disease.
    Drug Ther Bull; 1993 May; 31(10):39-40. PubMed ID: 8344135
    [No Abstract]   [Full Text] [Related]  

  • 10. Administering radioiodine treatment; alternative to nuclear medicine prescribing.
    Salvatori M; Mansi L
    Eur J Nucl Med Mol Imaging; 2007 Sep; 34(9):1512-3. PubMed ID: 17503038
    [No Abstract]   [Full Text] [Related]  

  • 11. Comments regarding Practice Recommendations of the American Thyroid Association for radiation safety in the treatment of thyroid disease with radioiodine.
    Hennessey JV; Parker JA; Kennedy R; Garber JR
    Thyroid; 2012 Mar; 22(3):336-7; author reply 337-8. PubMed ID: 22304332
    [No Abstract]   [Full Text] [Related]  

  • 12. [Radioiodine--today's trends in treatment of benign thyroid diseases].
    Łabuzek K; Kukla U; Chronowska J; Madej P; Okopień Bogusław
    Wiad Lek; 2014; 67(2 Pt 1):80-4. PubMed ID: 25764781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Follow-up results of 131-I therapy of benign thyroid diseases: an unsolved problem of dosimetry].
    Falkensammer M; Ladurner D; Riccabona G
    Strahlentherapie Sonderb; 1975; 74():64-73. PubMed ID: 1198676
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effective half-time value in radioiodine therapy of the thyroid gland (proceedings)].
    Hliscs R; Hennig K
    Radiol Diagn (Berl); 1978 Feb; 19(1):92. PubMed ID: 663124
    [No Abstract]   [Full Text] [Related]  

  • 15. Optimized dose planning of radioiodine therapy of benign thyroidal diseases.
    Bockisch A; Jamitzky T; Derwanz R; Biersack HJ
    J Nucl Med; 1993 Oct; 34(10):1632-8. PubMed ID: 8410273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iodine-131 for therapy of thyroid diseases. Physical and biological basis.
    Wyszomirska A
    Nucl Med Rev Cent East Eur; 2012 Aug; 15(2):120-3. PubMed ID: 22936505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dose calculation for thyroid radiation therapy according to MIRD recommendations (author's transl)].
    Tautz M
    Radiobiol Radiother (Berl); 1976; 17(1):71-5. PubMed ID: 935371
    [No Abstract]   [Full Text] [Related]  

  • 18. [Reduction of thyroid volume following radioiodine therapy for functional autonomy].
    Luster M; Jacob M; Thelen MH; Michalowski U; Deutsch U; Reiners C
    Nuklearmedizin; 1995 Apr; 34(2):57-60. PubMed ID: 7761274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional differences in opinions on adjuvant radioactive iodine treatment of thyroid carcinoma within Canada and the United States.
    Sawka AM; Rotstein L; Brierley JD; Tsang RW; Thabane L; Gafni A; Straus S; Kamalanathan S; Zhao B; Goldstein DP; Rambaldini G; Ezzat S
    Thyroid; 2007 Dec; 17(12):1235-42. PubMed ID: 17988197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioiodine treatment for benign thyroid diseases.
    Weetman AP
    Clin Endocrinol (Oxf); 2007 Jun; 66(6):757-64. PubMed ID: 17466000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.